Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation.

Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB.

Psychiatry Res. 1993 Dec;49(3):257-72.

PMID:
8177920
2.

Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.

Pazzaglia PJ, Post RM, Ketter TA, Callahan AM, Marangell LB, Frye MA, George MS, Kimbrell TA, Leverich GS, Cora-Locatelli G, Luckenbaugh D.

J Clin Psychopharmacol. 1998 Oct;18(5):404-13.

PMID:
9790159
3.
4.

Ultra-rapid and ultradian cycling in bipolar affective illness.

Kramlinger KG, Post RM.

Br J Psychiatry. 1996 Mar;168(3):314-23.

PMID:
8833685
5.

[Phase prevention in bipolar affective disorder with nimodipine. A case report].

Hesslinger B, Riedel H, Hellwig B, Walden J, Berger M.

Nervenarzt. 1996 May;67(5):394-6. German.

PMID:
9005349
6.

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.

Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W; BOLDER Study Group.

Bipolar Disord. 2007 Jun;9(4):413-25.

PMID:
17547587
9.
10.

Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness.

Davanzo PA, Krah N, Kleiner J, McCracken J.

J Child Adolesc Psychopharmacol. 1999;9(1):51-61.

PMID:
10357518
11.
12.

Lithium versus placebo in acute depression: a clinical trial.

Khan MC, Wickham EA, Reed JV.

Int Clin Psychopharmacol. 1987 Jan;2(1):47-54.

PMID:
3117877
13.

Depression with versus without manic features in rapid-cycling bipolar disorder.

Goldberg JF, Wankmuller MM, Sutherland KH.

J Nerv Ment Dis. 2004 Sep;192(9):602-6.

PMID:
15348976
14.

Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.

Post RM, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H.

J Clin Psychiatry. 2005 Mar;66(3):370-4.

PMID:
15766304
15.
16.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
17.

[Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].

Sarfati Y, Spadone C, Vanelle JM, Lôo H.

Encephale. 1996 Mar-Apr;22(2):149-53. Review. French.

PMID:
8706625
18.

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.

Potkin SG, Keck PE Jr, Segal S, Ice K, English P.

J Clin Psychopharmacol. 2005 Aug;25(4):301-10.

PMID:
16012271
19.

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH; SPD417 Study Group.

J Clin Psychiatry. 2005 Mar;66(3):323-30. Erratum in: J Clin Psychiatry. 2005 May;66(5):659.

PMID:
15766298
20.

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM.

J Clin Psychiatry. 1997 Nov;58(11):470-8.

PMID:
9413412

Supplemental Content

Support Center